Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Journal of comparative neurology

• Publication date

  1999-06-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9861(19990621)409:1<25::AID-CNE3>3.0.CO;2-EPMID 10363709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain dopamine D-2 receptors in senile dementia

  2005cited by this paper
• Severe panencephalic Pick's disease with Alzheimer's disease-like neuropil threads and synaptophysin immunoreactivity

  2004cited by this paper
• Immunocytochemical localization of the dopamine transporter in human brain

  1999cited by this paper
• m2 muscarinic acetylcholine receptor‐immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: Relationship with cholinergic and galaninergic perikarya

  1998cited by this paper
• Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys

  1998cited by this paper
• Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

  1998cited by this paper
• Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease

  1998cited by this paper
• Striatal uptake of the dopamine reuptake ligand [11C]β-CFT is reduced in Alzheimer's disease assessed by positron emission tomography

  1998cited by this paper
• Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease

  1997cited by this paper
• VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

  1997cited by this paper
• Immunochemical analysis of dopamine transporter protein in Parkinson's disease

  1997cited by this paper
• Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.

  1997cited by this paper
• Counting on our reviewers to set the standards

  1997cited by this paper
• Quantification without pontification: Choosing a method for counting objects in sectioned tissues

  1997cited by this paper
• Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter

  1997cited by this paper
• Age‐related and regional differences in dopamine transporter mRNA expression in human midbrain

  1997cited by this paper
• The role of the immune system in neurodegenerative disorders

  1997cited by this paper
• Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP

  1997cited by this paper
• Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra

  1997cited by this paper
• Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

  1996cited by this paper
• The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

  1996cited by this paper
• The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.

  1996cited by this paper
• Dopamine transporters decrease with age.

  1996cited by this paper
• Methods for determining numbers of cells and synapses: A case for more uniform standards of review

  1996cited by this paper
• Any way you cut it: A new journal policy for the use of unbiased counting methods

  1996cited by this paper
• Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method

  1996cited by this paper
• Human orbitofrontal cortex: Cytoarchitecture and quantitative immunohistochemical parcellation

  1995cited by this paper
• Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease

  1995cited by this paper
• Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls

  1995cited by this paper
• Embedding, sectioning, immunocytochemical and stereological methods that optimise research on the lesioned adult rat spinal cord.

  1995cited by this paper
• Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

  1995cited by this paper
• The dopamine transporter: immunochemical characterization and localization in brain

  1995cited by this paper
• Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

  1994cited by this paper
• New stereological methods for counting neurons.

  1993cited by this paper
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a

  1992cited by this paper
• A consideration of neural counting methods.

  1992cited by this paper
• Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.

  1991cited by this paper
• The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

  1991cited by this paper
• Age‐related changes in the human nigrostriatal dopaminergic system

  1990cited by this paper
• Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum

  1989cited by this paper
• Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

  1989cited by this paper
• Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease

  1988cited by this paper
• Human Motor Behavior and Aging

  1988cited by this paper
• The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis

  1988cited by this paper
• Decreased density of human striatal dopamine uptake sites with age.

  1986cited by this paper
• Stereology of arbitrary particles *

  1986cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

  1985cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.

  1984cited by this paper
• A serotonin-immunoreactive fiber system in the dorsal columns of the spinal cord.

  1982cited by this paper
• Dendritic release of dopamine in the substantia nigra

  1981cited by this paper
• Aging and extrapyramidal function.

  1977cited by this paper
• Neurologic changes in the aged.

  1956cited by this paper

• Human dental pulp stem cell-derived mitochondria restore mitochondrial function and promote neuroregeneration in a cellular model of Parkinson’s disease

  2025cites this paper
• Nuclear Medicine Imaging Biomarkers in Parkinson’s Disease: Past, Present, and Future Directions

  2025cites this paper
• Association between nigrosome-1 appearance on MRI and fine motor function in healthy adults and people living with Parkinson's disease.

  2025cites this paper
• Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality

  2024cites this paper
• Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives

  2024cites this paper
• The neurobiological effects of senescence on dopaminergic system: a comprehensive review.

  2024cites this paper
• Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary 18F-FDG PET/CT Study

  2023cites this paper
• Substantia nigral dopamine transporter uptake in dementia with Lewy bodies

  2023cites this paper
• Apoptotic factors and mitochondrial complexes assist determination of strain-specific susceptibility of mice to Parkinsonian neurotoxin MPTP

  2022cites this paper
• Hypoxia and Brain Aging: Neurodegeneration or Neuroprotection?

  2021cites this paper
• Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems

  2021cites this paper
• Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease

  2021cites this paper
• PET and SPECT Imaging of the Central Dopamine System in Humans

  2020cites this paper
• Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT

  2020cites this paper
• COMT Val158Met polymorphism associated with greater susceptibility to framing effects in healthy older adults

  2019cites this paper
• Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

  2019cites this paper
• Advanced Mass Spectrometry Imaging in Neuropharmacology

  2019cites this paper
• Age-related variability in decision-making: Insights from neurochemistry

  2018cites this paper
• A critical review of brain and cognitive reserve in Huntington's disease

  2018cites this paper
• Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain

  2018cites this paper
• Emotion Recognition Ability in Older Adults

  2018cites this paper
• A role for nanor in early zebrafish development and validation of a neurotoxic zebrafish model of Parkinson’s disease

  2018cites this paper
• No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice

  2018cites this paper
• Changes of Neurons and Blood Vessels of Human Substantia Nigra in Aging- Morphometric Study

  2017cites this paper
• Diminished stress resistance and defective adaptive homeostasis in age-related diseases.

  2017cites this paper
• Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia

  2017cites this paper
• Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT score

  2016cites this paper
• Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density

  2016cites this paper
• Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.

  2016cites this paper
• Title The ever-changing brain : Clinical implications Introduction Permalink

  2016cites this paper
• Ageing of the somatic motor nervous system: a nuclear and mitochondrial genome perspective

  2016cites this paper
• Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?☆

  2014cites this paper
• Progression of intestinal permeability changes and alpha‐synuclein expression in a mouse model of Parkinson's disease

  2014cites this paper
• Neuropathology of Parkinson’s Disease

  2014cites this paper
• Nuclear medicine methods in idiopathic Parkinsonism : pre- and postsynaptic dopamine SPECT

  2013cites this paper
• Vulnerable neural systems and the borderland of brain aging and neurodegeneration.

  2013cites this paper
• Gram-negative Sepsis: Studies in P47 Microvessel Injury Induced by Lung Neutrophil Sequestration and Role of Nadph Oxidase in the Mechanism Of

  2013cites this paper
• Methylphenidate treatment and rearing environment: Effects on the dopamine system and vulnerability to substance abuse in animal models

  2013cites this paper
• Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.

  2013cites this paper
• Parkinson ’ s disease is associated with altered expression of CaV 1 channels and calcium-binding proteins

  2013cites this paper
• Gram-negative Sepsis: Studies in P47 Microvessel Injury Induced by Lung Neutrophil Sequestration and Role of Nadph Oxidase in the Mechanism Of

  2013cites this paper
• Dopamine Transporter mRNA in Human Brain Distribution and Regulatory Effects in Autopsy Studies of Cocaine Abusers

  2012cites this paper
• Does training or deprivation modulate amygdala activation?

  2012cites this paper
• Activity‐dependent regulation of the dopamine phenotype in substantia nigra neurons

  2012cites this paper
• Avaliação do transportador dopaminérgico em jogadores patológicos através de imagens de SPECT com TRODAT-1- 99m Tc

  2012cites this paper
• Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

  2012cites this paper
• Chronic Treatment with Extended Release Methylphenidate Does Not Alter Dopamine Systems or Increase Vulnerability for Cocaine Self-Administration: A Study in Nonhuman Primates

  2012cites this paper
• Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice.

  2012cites this paper
• Substantia Nigra, Ventral Tegmental Area, and Retrorubral Fields

  2012cites this paper
• Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

  2012cites this paper
• MODERN STEREOLOGICAL EVALUATION IN THE AGING HUMAN SUBSTANTIA NIGRA

  2011influential citation
• Effect of low endogenous brain-derived neurotrophic factor levels on striatal dopamine dynamics

  2011cites this paper
• The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease

  2011cites this paper
• A dual-hit animal model for age-related parkinsonism.

  2010cites this paper
• Dopamine Transporter: Aging and Parkinson’s Disease

  2010cites this paper
• Lewy body pathology in fetal grafts

  2010cites this paper
• Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function

  2010cites this paper
• Age-related alterations in default mode network: impact on working memory performance.

  2010cites this paper
• Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues.

  2010influential citation
• Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians.

  2010cites this paper
• Interaction of psychostimulant intake with brain aging: Effects on behavioral capacity, oxidative damage and dopaminergic markers

  2009cites this paper
• A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

  2009cites this paper
• Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.

  2009cites this paper
• The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009

  2009cites this paper
• Aging effects on the dopamine transporter expression and compensatory mechanisms.

  2009cites this paper
• A critical reappraisal of current staging of Lewy-related pathology in human brain

  2008cites this paper
• Aging in rhesus macaques is associated with changes in novelty preference and altered saccade dynamics.

  2008cites this paper
• Morphometry of the human substantia nigra in ageing and Parkinson’s disease

  2008influential citation
• Muscarinic M1 and M3 Receptors,IP3 and cGMP Functional Regulation in Streptozotocin Induced Diabetic Rats: Insulin and Somatotropin Induced Rejuvenation as a Function of Age

  2008cites this paper
• Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

  2007influential citation
• Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

  2007cites this paper
• Age-related changes in the catecholaminergic neurons of the mesopontine tegmentum in the rat

  2007cites this paper
• Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex.

  2007cites this paper
• Alterations in prodynorphin, proenkephalin, and GAD67 mRNA levels in the aged human putamen: Correlation with Parkinson's disease

  2007influential citation
• Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys.

  2007cites this paper
• Expression Profile Analysis of Brain Aging

  2007cites this paper
• Distribution of the dopamine innervation in the macaque and human thalamus

  2007cites this paper
• From vice to virtue: insights from sensitization in the nonhuman primate.

  2007cites this paper
• Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT

  2007cites this paper
• Lewy Body Disorders

  2007cites this paper
• PONTIFÍCIA UNIVERSIDADE CATÓLICA DO RIO GRANDE DO SUL INSTITUTO DE GERIATRIA E GERONTOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM GERONTOLOGIA BIOMÉDICA DISSERTAÇÃO DE MESTRADO ESTUDO DA PARTICIPAÇÃO DO SISTEMA DOPAMINÉRGICO NA FORMAÇÃO DA MEMÓRIA DE RECONHECIMENTO EM RATOS.

  2006cites this paper
• The correlative triad among aging, dopamine, and cognition: current status and future prospects.

  2006influential citation
• Dopamine transporter is essential for the maintenance of spontaneous activity of auditory nerve neurones and their responsiveness to sound stimulation

  2006cites this paper
• NMDA modulation of dopamine dynamics is diminished in the aged striatum: an in vivo voltametric study.

  2006cites this paper
• Under the curve: critical issues for elucidating D1 receptor function in working memory.

  2006cites this paper
• Parkinson's disease and dopamine transporter neuroimaging – a critical review

  2006cites this paper
• Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease

  2006cites this paper
• A one‐carbon modification of protein lysine associated with elevated oxidative stress in human substantia nigra

  2006cites this paper
• RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys.

  2006cites this paper
• Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.

  2005cites this paper
• Sex differences in age-related motor slowing in the rhesus monkey: behavioral and neuroimaging data.

  2005cites this paper
• Dysfunction in Familial Alzheimer ’ s Disease-Linked APPswe / PS 1 E 9 Transgenic Mice

  2005influential citation
• The role of the striatal dopamine transporter in cognitive aging.

  2005cites this paper
• Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

  2005cites this paper
• Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice

  2005cites this paper
• Histological changes of the dopaminergic nigrostriatal system in aging

  2004influential citation
• Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

  2004cites this paper
• Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.

  2004cites this paper
• Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

  2004cites this paper
• Age-related changes in fear behavior and regional brain monoamines distribution in rats.

  2004cites this paper